{"transactions":[{"id":1430932,"issuer":{"id":85047,"kind":"organization","name":"BIORA THERAPEUTICS, INC.","symbol":"BIOR"},"owners":[{"id":88244,"kind":"person","name":"dEsparbes Eric","position":1,"cik":"0001622268","reported_name":"dEsparbes Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-08-16T16:05:04.000Z","date":"2024-08-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":27830,"price":0.67,"value":18646.1,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the release of vested restricted stock units."}],"balance_after":575832,"source":{"system":"sec-edgar","filing":"0000950170-24-098046","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1580063/000095017024098046/ownership.xml","form_type":"4"}},{"id":1640613,"issuer":{"id":85047,"kind":"organization","name":"BIORA THERAPEUTICS, INC.","symbol":"BIOR"},"owners":[{"id":88244,"kind":"person","name":"dEsparbes Eric","position":1,"cik":"0001622268","reported_name":"dEsparbes Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-02-15T16:05:20.000Z","date":"2024-02-15","kind":"grant","planned":false,"acquired":true,"shares":325000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of 325,000 restricted stock units, 25% of which will vest on February 15, 2025, with the remaining shares vesting in equal semi-annual installments through February 15, 2028, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":603662,"source":{"system":"sec-edgar","filing":"0000950170-24-015862","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1580063/000095017024015862/ownership.xml","form_type":"4"}},{"id":1802957,"issuer":{"id":85047,"kind":"organization","name":"BIORA THERAPEUTICS, INC.","symbol":"BIOR"},"owners":[{"id":88244,"kind":"person","name":"dEsparbes Eric","position":1,"cik":"0001622268","reported_name":"dEsparbes Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-08-17T16:22:47.000Z","date":"2023-08-15","kind":"grant","planned":false,"acquired":true,"shares":219650,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Consists of 219,650 restricted stock units, 25% of which will vest on August 15, 2024, with the remaining shares vesting in equal semi-annual installments through August 15, 2027, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":278662,"source":{"system":"sec-edgar","filing":"0000950170-23-043225","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1580063/000095017023043225/ownership.xml","form_type":"4"}},{"id":1802956,"issuer":{"id":85047,"kind":"organization","name":"BIORA THERAPEUTICS, INC.","symbol":"BIOR"},"owners":[{"id":88244,"kind":"person","name":"dEsparbes Eric","position":1,"cik":"0001622268","reported_name":"dEsparbes Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-08-17T16:22:47.000Z","date":"2023-08-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":40022,"price":3.14,"value":125669.08,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the release of vested RSUs."}],"balance_after":59012,"source":{"system":"sec-edgar","filing":"0000950170-23-043225","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1580063/000095017023043225/ownership.xml","form_type":"4"}},{"id":1888402,"issuer":{"id":85047,"kind":"organization","name":"BIORA THERAPEUTICS, INC.","symbol":"BIOR"},"owners":[{"id":88244,"kind":"person","name":"dEsparbes Eric","position":1,"cik":"0001622268","reported_name":"dEsparbes Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-05-17T16:56:23.000Z","date":"2023-05-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":2807,"price":3.35,"value":9403.45,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the release of vested RSUs."}],"balance_after":99034,"source":{"system":"sec-edgar","filing":"0000950170-23-022773","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1580063/000095017023022773/ownership.xml","form_type":"4"}},{"id":1945958,"issuer":{"id":85047,"kind":"organization","name":"BIORA THERAPEUTICS, INC.","symbol":"BIOR"},"owners":[{"id":88244,"kind":"person","name":"dEsparbes Eric","position":1,"cik":"0001622268","reported_name":"dEsparbes Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-03-17T21:16:50.000Z","date":"2023-03-15","kind":"tax_withholding","acquired":false,"shares":11216,"price":2.56,"value":28712.96,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the release of vested RSUs."}],"balance_after":101841,"source":{"system":"sec-edgar","filing":"0000899243-23-009032","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1580063/000089924323009032/doc4.xml","form_type":"4"}},{"id":1945957,"issuer":{"id":85047,"kind":"organization","name":"BIORA THERAPEUTICS, INC.","symbol":"BIOR"},"owners":[{"id":88244,"kind":"person","name":"dEsparbes Eric","position":1,"cik":"0001622268","reported_name":"dEsparbes Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-03-17T21:16:50.000Z","date":"2023-03-15","kind":"grant","acquired":true,"shares":22692,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Consists of 22,692 RSUs, which vested upon grant."}],"balance_after":113057,"source":{"system":"sec-edgar","filing":"0000899243-23-009032","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1580063/000089924323009032/doc4.xml","form_type":"4"}},{"id":1945956,"issuer":{"id":85047,"kind":"organization","name":"BIORA THERAPEUTICS, INC.","symbol":"BIOR"},"owners":[{"id":88244,"kind":"person","name":"dEsparbes Eric","position":1,"cik":"0001622268","reported_name":"dEsparbes Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-03-17T21:16:50.000Z","date":"2023-03-15","kind":"grant","acquired":true,"shares":62225,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of 62,225 restricted stock units (\"RSUs\"), 25% of which will vest on May 15, 2024, with the remaining shares vesting in equal semi-annual installments through May 15, 2027, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":90365,"source":{"system":"sec-edgar","filing":"0000899243-23-009032","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1580063/000089924323009032/doc4.xml","form_type":"4"}},{"id":2006576,"issuer":{"id":85047,"kind":"organization","name":"BIORA THERAPEUTICS, INC.","symbol":"BIOR"},"owners":[{"id":88244,"kind":"person","name":"dEsparbes Eric","position":1,"cik":"0001622268","reported_name":"dEsparbes Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-02-17T16:15:27.000Z","date":"2023-02-15","kind":"tax_withholding","acquired":false,"shares":269,"price":3.46,"value":930.74,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the release of 479 vested restricted stock units on February 15, 2023."}],"balance_after":28140,"source":{"system":"sec-edgar","filing":"0000899243-23-005465","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1580063/000089924323005465/doc4.xml","form_type":"4"}},{"id":2061729,"issuer":{"id":85047,"kind":"organization","name":"BIORA THERAPEUTICS, INC.","symbol":"BIOR"},"owners":[{"id":88244,"kind":"person","name":"dEsparbes Eric","position":1,"cik":"0001622268","reported_name":"dEsparbes Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Series X Preferred Stock","published_at":"2023-01-05T16:05:21.000Z","date":"2023-01-03","kind":"disposition_to_issuer","acquired":false,"shares":95,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On November 10, 2022, the Company's board of directors (the \"Board\") declared a dividend of one one-thousandth of a share of Series X Preferred Stock, par value $0.001 per share (the \"Preferred Stock\"), for each outstanding share of common stock to common stockholders of record at 5:00 p.m. Eastern Time on November 21, 2022, in a transaction exempt from Section 16 under Rule 16a-9. The shares of Preferred Stock were distributed on November 21, 2022. As a result, the Reporting Person received the shares of Preferred Stock set forth above. The Preferred Stock was not convertible into, or exchangeable for, shares of any other class or series of stock or other securities of the Company."},{"field":"shares","element":"transactionShares","label":"F2","text":"On January 3, 2023, in connection with the Company's reverse stock split for the common stock, the shares of Preferred Stock were redeemed automatically in accordance with the certificate of designation of the Preferred Stock. Each share of Preferred Stock was redeemed in consideration for the right to receive an amount equal to $0.001 in cash (rounded to the nearest cent) for each whole share of Preferred Stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On January 3, 2023, in connection with the Company's reverse stock split for the common stock, the shares of Preferred Stock were redeemed automatically in accordance with the certificate of designation of the Preferred Stock. Each share of Preferred Stock was redeemed in consideration for the right to receive an amount equal to $0.001 in cash (rounded to the nearest cent) for each whole share of Preferred Stock."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-23-000958","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1580063/000089924323000958/doc4.xml","form_type":"4"}},{"id":2114080,"issuer":{"id":85047,"kind":"organization","name":"BIORA THERAPEUTICS, INC.","symbol":"BIOR"},"owners":[{"id":88244,"kind":"person","name":"dEsparbes Eric","position":1,"cik":"0001622268","reported_name":"dEsparbes Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-11-16T21:48:01.000Z","date":"2022-11-15","kind":"tax_withholding","acquired":false,"shares":5194,"price":0.27,"value":1402.38,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the release of 10,474 vested restricted stock units on November 15, 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 6,887 shares acquired by the Reporting Person under the Issuer's 2020 Employee Stock Purchase Plan on May 31, 2021."}],"balance_after":710122,"source":{"system":"sec-edgar","filing":"0000899243-22-036077","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1580063/000089924322036077/doc4.xml","form_type":"4"}},{"id":2183644,"issuer":{"id":85047,"kind":"organization","name":"BIORA THERAPEUTICS, INC.","symbol":"BIOR"},"owners":[{"id":88244,"kind":"person","name":"dEsparbes Eric","position":1,"cik":"0001622268","reported_name":"dEsparbes Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-08-16T17:58:26.000Z","date":"2022-08-15","kind":"tax_withholding","acquired":false,"shares":5952,"price":1.04,"value":6190.08,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the release of 12,000 vested restricted stock units on August 15, 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 9,191 shares acquired by the Reporting Person under the Issuer's 2020 Employee Stock Purchase Plan on May 31, 2022."}],"balance_after":708429,"source":{"system":"sec-edgar","filing":"0000899243-22-028839","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1580063/000089924322028839/doc4.xml","form_type":"4"}},{"id":2267396,"issuer":{"id":85047,"kind":"organization","name":"BIORA THERAPEUTICS, INC.","symbol":"BIOR"},"owners":[{"id":88244,"kind":"person","name":"dEsparbes Eric","position":1,"cik":"0001622268","reported_name":"dEsparbes Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-05-17T17:18:56.000Z","date":"2022-05-15","kind":"grant","acquired":true,"shares":472495,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option represents the right to purchase 472,495 shares of the Issuer's common stock, 9,843 of which vested upon grant, with the remaining shares vesting in equal monthly installments through April 15, 2026, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":472495,"derivative":{"exercise_price":0.75,"expiration_date":"2032-05-15","underlying":"Common Stock","underlying_shares":472495},"source":{"system":"sec-edgar","filing":"0000899243-22-018428","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1580063/000089924322018428/doc4.xml","form_type":"4"}},{"id":2267395,"issuer":{"id":85047,"kind":"organization","name":"BIORA THERAPEUTICS, INC.","symbol":"BIOR"},"owners":[{"id":88244,"kind":"person","name":"dEsparbes Eric","position":1,"cik":"0001622268","reported_name":"dEsparbes Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-05-17T17:18:56.000Z","date":"2022-05-15","kind":"grant","acquired":true,"shares":292406,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Consists of 292,406 restricted stock units, 25% of which will vest on May 15, 2023, with the remaining shares vesting in equal semi-annual installments through May 15, 2026, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":705190,"source":{"system":"sec-edgar","filing":"0000899243-22-018428","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1580063/000089924322018428/doc4.xml","form_type":"4"}},{"id":2267394,"issuer":{"id":85047,"kind":"organization","name":"BIORA THERAPEUTICS, INC.","symbol":"BIOR"},"owners":[{"id":88244,"kind":"person","name":"dEsparbes Eric","position":1,"cik":"0001622268","reported_name":"dEsparbes Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-05-17T17:18:56.000Z","date":"2022-05-15","kind":"tax_withholding","acquired":false,"shares":10387,"price":0.75,"value":7790.25,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the release of 20,948 vested restricted stock units on May 15, 2022."}],"balance_after":412784,"source":{"system":"sec-edgar","filing":"0000899243-22-018428","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1580063/000089924322018428/doc4.xml","form_type":"4"}},{"id":2294522,"issuer":{"id":85047,"kind":"organization","name":"BIORA THERAPEUTICS, INC.","symbol":"BIOR"},"owners":[{"id":88244,"kind":"person","name":"dEsparbes Eric","position":1,"cik":"0001622268","reported_name":"dEsparbes Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-04-19T16:23:04.000Z","date":"2022-04-15","kind":"grant","acquired":true,"shares":375032,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option represents the right to purchase 375,032 shares of the Issuer's common stock, 7,813 of which vested upon grant, with the remaining shares vesting in equal monthly installments through March 15, 2026, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":375032,"derivative":{"exercise_price":1,"expiration_date":"2032-04-15","underlying":"Common Stock","underlying_shares":375032},"source":{"system":"sec-edgar","filing":"0000899243-22-015063","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1580063/000089924322015063/doc4.xml","form_type":"4"}},{"id":2294521,"issuer":{"id":85047,"kind":"organization","name":"BIORA THERAPEUTICS, INC.","symbol":"BIOR"},"owners":[{"id":88244,"kind":"person","name":"dEsparbes Eric","position":1,"cik":"0001622268","reported_name":"dEsparbes Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-04-19T16:23:04.000Z","date":"2022-04-15","kind":"grant","acquired":true,"shares":231693,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of 231,693 restricted stock units, 25% of which will vest on May 15, 2023, with the remaining shares vesting in equal semi-annual installments through May 15, 2026, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":423171,"source":{"system":"sec-edgar","filing":"0000899243-22-015063","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1580063/000089924322015063/doc4.xml","form_type":"4"}},{"id":2387513,"issuer":{"id":85047,"kind":"organization","name":"BIORA THERAPEUTICS, INC.","symbol":"BIOR"},"owners":[{"id":88244,"kind":"person","name":"dEsparbes Eric","position":1,"cik":"0001622268","reported_name":"dEsparbes Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-02-17T16:05:44.000Z","date":"2022-02-15","kind":"tax_withholding","acquired":false,"shares":4919,"price":1.9,"value":9346.1,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the release of 12,001 vested restricted stock units on February 15, 2022."}],"balance_after":191478,"source":{"system":"sec-edgar","filing":"0000899243-22-006785","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1580063/000089924322006785/doc4.xml","form_type":"4"}},{"id":2599302,"issuer":{"id":85047,"kind":"organization","name":"BIORA THERAPEUTICS, INC.","symbol":"BIOR"},"owners":[{"id":88244,"kind":"person","name":"dEsparbes Eric","position":1,"cik":"0001622268","reported_name":"dEsparbes Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-08-17T16:00:54.000Z","date":"2021-08-15","kind":"tax_withholding","acquired":false,"shares":5718,"price":1.66,"value":9491.88,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the release of 16,530 vested restricted stock units on August 15, 2021."}],"balance_after":196397,"source":{"system":"sec-edgar","filing":"0000899243-21-033252","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1580063/000089924321033252/doc4.xml","form_type":"4"}},{"id":2744766,"issuer":{"id":85047,"kind":"organization","name":"BIORA THERAPEUTICS, INC.","symbol":"BIOR"},"owners":[{"id":88244,"kind":"person","name":"dEsparbes Eric","position":1,"cik":"0001622268","reported_name":"dEsparbes Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-04-19T21:32:40.000Z","date":"2021-04-15","kind":"grant","acquired":true,"shares":175790,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"deemedExecutionDate","element":"deemedExecutionDate","label":"F3","text":"This option represents the right to purchase 175,790 shares of the Issuer's common stock, 3,661 of which vested upon grant, with the remaining shares vesting in equal monthly installments through March 15, 2025, subject to the Reporting Person's continued service to the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option represents the right to purchase 175,790 shares of the Issuer's common stock, 3,661 of which vested upon grant, with the remaining shares vesting in equal monthly installments through March 15, 2025, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":175790,"derivative":{"exercise_price":3.41,"expiration_date":"2031-04-15","underlying":"Common Stock","underlying_shares":175790},"source":{"system":"sec-edgar","filing":"0000899243-21-016315","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1580063/000089924321016315/doc4.xml","form_type":"4"}},{"id":2744765,"issuer":{"id":85047,"kind":"organization","name":"BIORA THERAPEUTICS, INC.","symbol":"BIOR"},"owners":[{"id":88244,"kind":"person","name":"dEsparbes Eric","position":1,"cik":"0001622268","reported_name":"dEsparbes Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-04-19T21:32:40.000Z","date":"2021-04-15","kind":"tax_withholding","acquired":false,"shares":13690,"price":3.41,"value":46682.9,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the release of 39,589 vested restricted stock units on April 15, 2021."}],"balance_after":202115,"source":{"system":"sec-edgar","filing":"0000899243-21-016315","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1580063/000089924321016315/doc4.xml","form_type":"4"}},{"id":2744764,"issuer":{"id":85047,"kind":"organization","name":"BIORA THERAPEUTICS, INC.","symbol":"BIOR"},"owners":[{"id":88244,"kind":"person","name":"dEsparbes Eric","position":1,"cik":"0001622268","reported_name":"dEsparbes Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-04-19T21:32:40.000Z","date":"2021-04-15","kind":"grant","acquired":true,"shares":123382,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of 123,382 restricted stock units, 39,589 of which vested on the grant date and 20,948 of which will vest on May 15, 2022, with the remaining shares vesting in equal semi-annual installments through May 15, 2025, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":215805,"source":{"system":"sec-edgar","filing":"0000899243-21-016315","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1580063/000089924321016315/doc4.xml","form_type":"4"}},{"id":2781052,"issuer":{"id":85047,"kind":"organization","name":"BIORA THERAPEUTICS, INC.","symbol":"BIOR"},"owners":[{"id":88244,"kind":"person","name":"dEsparbes Eric","position":1,"cik":"0001622268","reported_name":"dEsparbes Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-17T17:38:13.000Z","date":"2021-03-15","kind":"grant","acquired":true,"shares":67953,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents the right to purchase 67,953 shares of the Issuer's common stock, and will vest in full on March 15, 2022."}],"balance_after":67953,"derivative":{"exercise_price":4.73,"expiration_date":"2031-03-15","underlying":"Common Stock","underlying_shares":67953},"source":{"system":"sec-edgar","filing":"0000899243-21-012227","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1580063/000089924321012227/doc4.xml","form_type":"4"}},{"id":2802562,"issuer":{"id":85047,"kind":"organization","name":"BIORA THERAPEUTICS, INC.","symbol":"BIOR"},"owners":[{"id":88244,"kind":"person","name":"dEsparbes Eric","position":1,"cik":"0001622268","reported_name":"dEsparbes Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-03-08T17:14:02.000Z","date":"2021-03-04","kind":"tax_withholding","acquired":false,"shares":1608,"price":4.05,"value":6512.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the release of 4,610 vested restricted stock units on March 4, 2021."}],"balance_after":92423,"source":{"system":"sec-edgar","filing":"0000899243-21-010405","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1580063/000089924321010405/doc4.xml","form_type":"4"}},{"id":2853342,"issuer":{"id":85047,"kind":"organization","name":"BIORA THERAPEUTICS, INC.","symbol":"BIOR"},"owners":[{"id":88244,"kind":"person","name":"dEsparbes Eric","position":1,"cik":"0001622268","reported_name":"dEsparbes Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-02-17T17:04:34.000Z","date":"2021-02-15","kind":"tax_withholding","acquired":false,"shares":5361,"price":5.6,"value":30021.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the release of 13,166 vested restricted stock units on February 15, 2021."}],"balance_after":94031,"source":{"system":"sec-edgar","filing":"0000899243-21-006918","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1580063/000089924321006918/doc4.xml","form_type":"4"}},{"id":2934195,"issuer":{"id":85047,"kind":"organization","name":"BIORA THERAPEUTICS, INC.","symbol":"BIOR"},"owners":[{"id":88244,"kind":"person","name":"dEsparbes Eric","position":1,"cik":"0001622268","reported_name":"dEsparbes Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-12-22T19:19:17.000Z","date":"2020-12-19","kind":"tax_withholding","acquired":false,"shares":1228,"price":6.32,"value":7760.96,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the release of 3,550 vested restricted stock units on December 19, 2020."}],"balance_after":99392,"source":{"system":"sec-edgar","filing":"0000899243-20-034873","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1580063/000089924320034873/doc4.xml","form_type":"4"}},{"id":3053510,"issuer":{"id":85047,"kind":"organization","name":"BIORA THERAPEUTICS, INC.","symbol":"BIOR"},"owners":[{"id":88244,"kind":"person","name":"dEsparbes Eric","position":1,"cik":"0001622268","reported_name":"dEsparbes Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-08-18T21:42:18.000Z","date":"2019-06-15","kind":"grant","acquired":true,"shares":28406,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option represents the right to purchase 28,406 shares of the Issuer's common stock, 8,285 of which have vested as of June 18, 2020, with the remaining shares vesting in equal monthly installments through June 15, 2023, subject to the Reporting Person's continued service to the Issuer. The Reporting Person's Form 3 filed on June 18, 2020 reported the total number of shares underlying the derivative security as 28,407 due to a rounding error."}],"balance_after":28406,"derivative":{"exercise_price":9.88,"expiration_date":"2029-06-15","underlying":"Common Stock","underlying_shares":28406},"source":{"system":"sec-edgar","filing":"0000899243-20-022858","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1580063/000089924320022858/doc4.xml","form_type":"4"}},{"id":3053509,"issuer":{"id":85047,"kind":"organization","name":"BIORA THERAPEUTICS, INC.","symbol":"BIOR"},"owners":[{"id":88244,"kind":"person","name":"dEsparbes Eric","position":1,"cik":"0001622268","reported_name":"dEsparbes Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-08-18T21:42:18.000Z","date":"2020-08-15","kind":"grant","acquired":true,"shares":73863,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option represents the right to purchase 73,863 shares of the Issuer's common stock, which will vest in equal monthly installments from August 15, 2020 through July 15, 2024, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":73863,"derivative":{"exercise_price":7.71,"expiration_date":"2030-08-15","underlying":"Common Stock","underlying_shares":73863},"source":{"system":"sec-edgar","filing":"0000899243-20-022858","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1580063/000089924320022858/doc4.xml","form_type":"4"}},{"id":3053508,"issuer":{"id":85047,"kind":"organization","name":"BIORA THERAPEUTICS, INC.","symbol":"BIOR"},"owners":[{"id":88244,"kind":"person","name":"dEsparbes Eric","position":1,"cik":"0001622268","reported_name":"dEsparbes Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-08-18T21:42:18.000Z","date":"2020-08-15","kind":"grant","acquired":true,"shares":36243,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of 36,243 restricted stock units (\"RSUs\"), one quarter of which will vest on August 15, 2021, with the remaining three quarters vesting in semi-annual installments beginning on February 15, 2022 and ending on August 15, 2024, subject to the Reporting Person's continued service to the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Consists of 100,620 RSUs."}],"balance_after":100620,"source":{"system":"sec-edgar","filing":"0000899243-20-022858","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1580063/000089924320022858/doc4.xml","form_type":"4"}},{"id":3922535,"issuer":{"id":4679,"kind":"organization","name":"Innoviva, Inc."},"owners":[{"id":88244,"kind":"person","name":"dEsparbes Eric","position":1,"cik":"0001622268","reported_name":"dEsparbes Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and CFO"}}],"security":"Common Stock","published_at":"2018-05-22T23:53:23.000Z","date":"2018-05-21","kind":"sale","acquired":false,"shares":5808,"price":14.3979,"value":83623.0032,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"This sale was effected for tax planning purposes."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.3 to $14.62, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 1,924 shares of common stock acquired under the Innoviva, Inc. Employee Stock Purchase Plan on May 15, 2018."}],"balance_after":373081,"source":{"system":"sec-edgar","filing":"0001179110-18-007383","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1080014/000117911018007383/edgar.xml","form_type":"4"}},{"id":3922534,"issuer":{"id":4679,"kind":"organization","name":"Innoviva, Inc."},"owners":[{"id":88244,"kind":"person","name":"dEsparbes Eric","position":1,"cik":"0001622268","reported_name":"dEsparbes Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and CFO"}}],"security":"Common Stock","published_at":"2018-05-22T23:53:23.000Z","date":"2018-05-20","kind":"tax_withholding","acquired":false,"shares":7901,"price":14.59,"value":115275.59,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were withheld by the Issuer to satisfy income tax withholding obligations associated with the quarterly vesting of previously granted employee equity grants."}],"balance_after":376965,"source":{"system":"sec-edgar","filing":"0001179110-18-007383","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1080014/000117911018007383/edgar.xml","form_type":"4"}},{"id":4012023,"issuer":{"id":4679,"kind":"organization","name":"Innoviva, Inc."},"owners":[{"id":88244,"kind":"person","name":"dEsparbes Eric","position":1,"cik":"0001622268","reported_name":"dEsparbes Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim PEO, SVP and CFO"}}],"security":"Common Stock","published_at":"2018-03-06T21:14:17.000Z","date":"2018-03-02","kind":"grant","acquired":true,"shares":93056,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Includes 31,018 shares of common stock granted pursuant to a time-based restricted stock award (RSA). Twenty-five percent of the shares subject to the RSA shall vest on February 20, 2019, and 6.25% of the shares subject to the RSA shall vest quarterly thereafter on the Issuer's standard vesting dates until February 20, 2022, provided the Reporting Person has provided continuous service to the Issuer through the applicable vesting date."},{"field":"shares","element":"transactionShares","label":"F2","text":"Includes shares of common stock granted pursuant to a performance-based restricted stock award (PSA). The shares vest pursuant to the PSA over a three-year period upon, and subject to a formula related to, the Issuer's achievement of certain levels of relative total shareholder return (TSR). The \"target\" number of shares that may vest is 31,019, but the actual number of shares that may vest will range from 0 to 62,038 shares based on the Issuer's relative TSR over the performance period. Subject to achievement of the performance-based vesting conditions, the shares eligible to vest based on achievement will vest on February 20, 2021 provided that the Reporting Person has provided continuous service to the Issuer through the applicable vesting date."}],"balance_after":384866,"source":{"system":"sec-edgar","filing":"0001179110-18-003604","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1080014/000117911018003604/edgar.xml","form_type":"4"}},{"id":4041189,"issuer":{"id":4679,"kind":"organization","name":"Innoviva, Inc."},"owners":[{"id":88244,"kind":"person","name":"dEsparbes Eric","position":1,"cik":"0001622268","reported_name":"dEsparbes Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim PEO, SVP and CFO"}}],"security":"Common Stock","published_at":"2018-02-22T21:24:12.000Z","date":"2018-02-21","kind":"sale","acquired":false,"shares":5378,"price":16.5164,"value":88825.1992,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"This sale was effected for tax planning purposes pursuant to the Reporting Person's Rule 10b5-1 Trading Plan dated September 20, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $16.31 to $16.62, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 322 shares of common stock acquired under the Innoviva, Inc. Employee Stock Purchase Plan on November 15, 2017."}],"balance_after":291810,"source":{"system":"sec-edgar","filing":"0001179110-18-002589","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1080014/000117911018002589/edgar.xml","form_type":"4"}},{"id":4041188,"issuer":{"id":4679,"kind":"organization","name":"Innoviva, Inc."},"owners":[{"id":88244,"kind":"person","name":"dEsparbes Eric","position":1,"cik":"0001622268","reported_name":"dEsparbes Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim PEO, SVP and CFO"}}],"security":"Common Stock","published_at":"2018-02-22T21:24:12.000Z","date":"2018-02-20","kind":"tax_withholding","acquired":false,"shares":24876,"price":16.44,"value":408961.44,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were withheld by the Issuer to satisfy income tax withholding obligations associated with the quarterly vesting of previously granted employee equity grants."}],"balance_after":297188,"source":{"system":"sec-edgar","filing":"0001179110-18-002589","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1080014/000117911018002589/edgar.xml","form_type":"4"}},{"id":4153136,"issuer":{"id":4679,"kind":"organization","name":"Innoviva, Inc."},"owners":[{"id":88244,"kind":"person","name":"dEsparbes Eric","position":1,"cik":"0001622268","reported_name":"dEsparbes Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and CFO"}}],"security":"Common Stock","published_at":"2017-11-22T21:51:07.000Z","date":"2017-11-21","kind":"sale","acquired":false,"shares":13460,"price":13.3114,"value":179171.444,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"This sale was effected for tax planning purposes pursuant to the Reporting Person's Rule 10b5-1 Trading Plan dated September 20, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.21 to $13.46, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4."}],"balance_after":321742,"source":{"system":"sec-edgar","filing":"0001179110-17-014573","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1080014/000117911017014573/edgar.xml","form_type":"4"}},{"id":4153135,"issuer":{"id":4679,"kind":"organization","name":"Innoviva, Inc."},"owners":[{"id":88244,"kind":"person","name":"dEsparbes Eric","position":1,"cik":"0001622268","reported_name":"dEsparbes Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and CFO"}}],"security":"Common Stock","published_at":"2017-11-22T21:51:07.000Z","date":"2017-11-20","kind":"sale","acquired":false,"shares":1825,"price":13.04,"value":23798.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"This sale was effected for tax planning purposes pursuant to the Reporting Person's Rule 10b5-1 Trading Plan dated December 15, 2016."}],"balance_after":335202,"source":{"system":"sec-edgar","filing":"0001179110-17-014573","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1080014/000117911017014573/edgar.xml","form_type":"4"}},{"id":4153134,"issuer":{"id":4679,"kind":"organization","name":"Innoviva, Inc."},"owners":[{"id":88244,"kind":"person","name":"dEsparbes Eric","position":1,"cik":"0001622268","reported_name":"dEsparbes Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and CFO"}}],"security":"Common Stock","published_at":"2017-11-22T21:51:07.000Z","date":"2017-11-20","kind":"tax_withholding","acquired":false,"shares":6141,"price":13.17,"value":80876.97,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were withheld by the Issuer to satisfy income tax withholding obligations associated with the quarterly vesting of previously granted employee equity grants."}],"balance_after":337027,"source":{"system":"sec-edgar","filing":"0001179110-17-014573","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1080014/000117911017014573/edgar.xml","form_type":"4"}},{"id":4227791,"issuer":{"id":4679,"kind":"organization","name":"Innoviva, Inc."},"owners":[{"id":88244,"kind":"person","name":"dEsparbes Eric","position":1,"cik":"0001622268","reported_name":"dEsparbes Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and CFO"}}],"security":"Common Stock","published_at":"2017-08-22T20:37:00.000Z","date":"2017-08-21","kind":"sale","acquired":false,"shares":1825,"price":12.2,"value":22265.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"This sale was effected for tax planning purposes pursuant to the Reporting Person's Rule 10b5-1 Trading Plan dated December 15, 2016."}],"balance_after":343168,"source":{"system":"sec-edgar","filing":"0001179110-17-011728","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1080014/000117911017011728/edgar.xml","form_type":"4"}},{"id":4227790,"issuer":{"id":4679,"kind":"organization","name":"Innoviva, Inc."},"owners":[{"id":88244,"kind":"person","name":"dEsparbes Eric","position":1,"cik":"0001622268","reported_name":"dEsparbes Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and CFO"}}],"security":"Common Stock","published_at":"2017-08-22T20:37:00.000Z","date":"2017-08-20","kind":"tax_withholding","acquired":false,"shares":5770,"price":12.28,"value":70855.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were withheld by the Company to satisfy income tax withholding obligations associated with the quarterly vesting of previously granted employee equity awards."}],"balance_after":344993,"source":{"system":"sec-edgar","filing":"0001179110-17-011728","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1080014/000117911017011728/edgar.xml","form_type":"4"}},{"id":4308620,"issuer":{"id":4679,"kind":"organization","name":"Innoviva, Inc."},"owners":[{"id":88244,"kind":"person","name":"dEsparbes Eric","position":1,"cik":"0001622268","reported_name":"dEsparbes Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and CFO"}}],"security":"Common Stock","published_at":"2017-05-23T20:15:02.000Z","date":"2017-05-22","kind":"sale","acquired":false,"shares":1825,"price":11.85,"value":21626.25,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"This sale was effected for tax planning purposes pursuant to the Reporting Person's Rule 10b5-1 Trading Plan dated December 15, 2016."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 2,500 shares of common stock acquired under the Innoviva, Inc. Employee Stock Purchase Plan on May 15, 2017."}],"balance_after":350763,"source":{"system":"sec-edgar","filing":"0001179110-17-007830","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1080014/000117911017007830/edgar.xml","form_type":"4"}},{"id":4308619,"issuer":{"id":4679,"kind":"organization","name":"Innoviva, Inc."},"owners":[{"id":88244,"kind":"person","name":"dEsparbes Eric","position":1,"cik":"0001622268","reported_name":"dEsparbes Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and CFO"}}],"security":"Common Stock","published_at":"2017-05-23T20:15:02.000Z","date":"2017-05-20","kind":"tax_withholding","acquired":false,"shares":4208,"price":11.86,"value":49906.88,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were withheld by the Issuer to satisfy income tax withholding obligations associated with the quarterly vesting of previously granted employee equity awards."}],"balance_after":352588,"source":{"system":"sec-edgar","filing":"0001179110-17-007830","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1080014/000117911017007830/edgar.xml","form_type":"4"}},{"id":4432717,"issuer":{"id":4679,"kind":"organization","name":"Innoviva, Inc."},"owners":[{"id":88244,"kind":"person","name":"dEsparbes Eric","position":1,"cik":"0001622268","reported_name":"dEsparbes Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and CFO"}}],"security":"Common Stock","published_at":"2017-02-22T21:30:34.000Z","date":"2017-02-21","kind":"sale","acquired":false,"shares":1825,"price":12.07,"value":22027.75,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"This sale was effected for tax planning purposes pursuant to the Reporting Person's Rule 10b5-1 Trading Plan dated December 15, 2016."}],"balance_after":354296,"source":{"system":"sec-edgar","filing":"0001179110-17-002898","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1080014/000117911017002898/edgar.xml","form_type":"4"}},{"id":4432716,"issuer":{"id":4679,"kind":"organization","name":"Innoviva, Inc."},"owners":[{"id":88244,"kind":"person","name":"dEsparbes Eric","position":1,"cik":"0001622268","reported_name":"dEsparbes Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and CFO"}}],"security":"Common Stock","published_at":"2017-02-22T21:30:34.000Z","date":"2017-02-20","kind":"tax_withholding","acquired":false,"shares":8604,"price":12.04,"value":103592.16,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were withheld by the Issuer to satisfy income tax withholding obligations associated with the quarterly vesting of previously granted employee equity awards."}],"balance_after":356121,"source":{"system":"sec-edgar","filing":"0001179110-17-002898","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1080014/000117911017002898/edgar.xml","form_type":"4"}},{"id":4486979,"issuer":{"id":4679,"kind":"organization","name":"Innoviva, Inc."},"owners":[{"id":88244,"kind":"person","name":"dEsparbes Eric","position":1,"cik":"0001622268","reported_name":"dEsparbes Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and CFO"}}],"security":"Common Stock","published_at":"2017-01-20T01:22:52.000Z","date":"2017-01-17","kind":"grant","acquired":true,"shares":133398,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Includes 66,698 shares of common stock granted pursuant to a time-based restricted stock award (RSA).  Twenty-five percent of the shares subject to the RSA shall vest on February 20, 2018, and 6.25% of the shares subject to the RSA shall vest quarterly thereafter on the Issuer's standard vesting dates until February 20, 2021, provided that the Reporting Person has provided continuous service to the Issuer through the applicable vesting date."},{"field":"shares","element":"transactionShares","label":"F2","text":"Includes shares of common stock granted pursuant to a performance-based restricted stock award (PSA).  The shares vest pursuant to the PSA over a two-year and three-year performance period upon, and subject to a formula related to, the Issuer's achievement of certain levels of relative total shareholder return (TSR).  The \"target\" number of shares that may vest is 33,350 but the actual number of shares that may vest will range from 0 to 66,700 shares based on the Issuer's relative TSR over the performance periods.  Subject to achievement of the performance-based vesting conditions, (i) two-thirds of the shares eligible to vest based on achievement for the two-year performance period will vest on February 20, 2019 and the remaining one-third of such shares will vest on February 20, 2020 and (ii) the share eligible to vest based on achievement for the three-year performance period will vest on February 20, 2020, in each case, (continued in Footnote 3)"},{"field":"shares","element":"transactionShares","label":"F3","text":"(continued from Footnote 2) provided that the Reporting Person has provided continuous service to the Issuer through the applicable vesting date."}],"balance_after":364725,"source":{"system":"sec-edgar","filing":"0001179110-17-001081","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1080014/000117911017001081/edgar.xml","form_type":"4"}},{"id":4545587,"issuer":{"id":4679,"kind":"organization","name":"Innoviva, Inc."},"owners":[{"id":88244,"kind":"person","name":"dEsparbes Eric","position":1,"cik":"0001622268","reported_name":"dEsparbes Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and CFO"}}],"security":"Common Stock","published_at":"2016-11-22T22:45:43.000Z","date":"2016-11-21","kind":"sale","acquired":false,"shares":1800,"price":10.89,"value":19602.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"This sale was effected for tax planning purposes pursuant to the Reporting Person's Rule 10b5-1 Trading Plan dated May 20, 2016."}],"balance_after":231327,"source":{"system":"sec-edgar","filing":"0001179110-16-031973","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1080014/000117911016031973/edgar.xml","form_type":"4"}},{"id":4545586,"issuer":{"id":4679,"kind":"organization","name":"Innoviva, Inc."},"owners":[{"id":88244,"kind":"person","name":"dEsparbes Eric","position":1,"cik":"0001622268","reported_name":"dEsparbes Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and CFO"}}],"security":"Common Stock","published_at":"2016-11-22T22:45:43.000Z","date":"2016-11-20","kind":"tax_withholding","acquired":false,"shares":3832,"price":10.91,"value":41807.12,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were withheld by the Issuer to satisfy income tax withholding obligations associated with the quarterly vesting of previously granted employee equity awards."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 766 shares of common stock acquired under the Innoviva, Inc. Employee Stock Purchase Plan on November 15, 2016."}],"balance_after":233127,"source":{"system":"sec-edgar","filing":"0001179110-16-031973","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1080014/000117911016031973/edgar.xml","form_type":"4"}}]}